The age distribution of antibody to the human reovirus-like enteritis agent, and to the antigenically related Nebraska calf diarrhea virus (NCDV) was studied in serum specimens obtained from 592 children hospitalized in Boston. Sera were examined for complement-fixation (CF) antibody to the human agent, and for CF and indirect immunofluorescence-staining antibodies to NCDV. The curve of antibody frequency was similar in each of the three assays, showing a steep rise in the 6-to 18-month-old age groups; these results indicate the early acquisition of antibody to the reovirus-like enteritis agent. The majority of children and young adults possessed CF-and immunofluorescence-stainable antibodies. There was a significant association between antibody prevalence data obtained with the human CF antigen and with the two NCDV antigens; this association was closest between the human and NCDV CF antigens.
A reovirus-like agent, referred to as an orbivirus, rotavirus and duovirus by various laboratories, now appears to be a major cause of enteric disease in infants and young children (2, 3, 7, 10, 15) . The agent has been visualized by electron microscopy in epithelial cells of duodenal mucosa (1) and in stool extracts from infants and young children with gastroenteritis (2, 3, 7, 10, 15) . Furthermore, infection is accompanied by a serological response to the agent, as measured by immune electron microscopy, complement fixation (CF), and indirect immunofluorescence (FA) (3, (8) (9) (10) (11) 17) . Certain assays for serum antibody to the reovirus-like agent are cumbersome and are unlikely to be suitable for large-scale seroepidemiological studies since they require the use of an electron microscope or sections of human fetal intestinal organ culture infected with the agent. However, serological studies appear to have been greatly facilitated by the observation that this agent is antigenically related to a morphologically similar virus, Nebraska calf diarrhea virus (NCDV) (3, (8) (9) (10) (11) . NCDV, unlike the human reovirus-like agent, readily grows in cell cultures and therefore has been used successfully as a convenient substitute antigen for the human reovirus-like agent in CF and FA tests. Only one preliminary serological survey of the age prevalence of CF antibody to the human reovirus-like agent and NCDV has been reported (11) . This survey indicated that approximately one-half of normal infants admitted to a Washington, D.C. welfare institution possessed antibody by 6 to 12 months of age. The present study was undertaken to determine the age distribution of antibody to the reovirus-like agent in hospitalized Boston area children, and to determine the relationship of antibody responses that were observed by three serological techniques.
MATERIALS AND METHODS Serum specimens. Aliquots of refrigerated sera, collected 1 to 5 days earlier for diagnostic purposes unrelated to this study, were kindly provided by the clinical chemistry laboratory of the Children's Hospital Medical Center of Boston. All specimens were obtained from children who were hospitalized during the months of February, March, and April of 1975. Children hospitalized with acute or chronic inflammatory gastrointestinal disease or hematological disease requiring transfusion were excluded. All children were residents of the metropolitan Boston area. Five hundred ninety-two sera were studied that tested satisfactorily in CF and FA; one serum specimen was studied per child.
Fluorescent-staining antibody tests. Sera were diluted 1:4 in phosphate-buffered saline (PBS), pH 7.4 , and studied in indirect FA tests for reactivity against NCDV. The FA test for human antibody against NCDV has been used in several studies (5, 8, 9, 11) . The procedure followed described methods (4-6, 11, 14, 16) . Briefly, a passage of the Cody strain (6, 14, 16) CF tests. Sera were tested at a 1:4 dilution in CF against the human reovirus-like agent, according to described technique (10) . A 2% stool filtrate (10), derived from a 16-month-old child hospitalized with gastroenteritis, was used as antigen. This filtrate contained the reovirus-like particle, as determined by immune electron microscopy reaction (10) with convalescent serum from the child. Acute illness and 3-week convalescent (paired) sera from this child demonstrated an eightfold rise in CF-antibody titer against the homologous stool particle and a fourfold rise in FA-staining antibody titer against NCDV. Paired sera from two other children hospitalized with gastroenteritis, whose stool filtrates contained the reovirus-like particle, also showed a fourfold or greater rise in CF-antibody titer to the CF antigen and in FA-staining antibody titer against NCDV. Paired sera from six children, whose stool filtrates were negative for the reovirus-like particle, failed to demonstrate a rise in antibody titer to the CF and FA antigens. CF tests were performed by the microtiter method, using 16 to 32 U of antigen.
Sera were also tested at a 1:4 dilution in CF against NCDV according to described technique (11) . A strong, positive association between human CF-antibody responses to the human reovirus-like agent and NCDV has already been reported (11) . NCDV stock pools were grown and concentrated 25-fold, and the concentrates were used undiluted in CF as described (11) . All three children described above, who seroconverted to the human reoviruslike CF antigen, also developed a fourfold or greater CF-antibody rise to the concentrated NCDV antigen.
RESULTS
Age distribution of human antibody. Prevalence of human antibody to the reovirus-like agent and NCDV in different age groups was examined as shown in Fig. 1 . Five hundred ninety-two sera were tested for FA-staining antibody to NCDV and for CF antibody to the human reovirus-like agent (Fig. 1, A and B) ; 428 of these sera were also examined for CF antibody to NCDV (Fig. 1, C) . For Fig. 1, A and B, the point for each age group represents results obtained with 50 sera, with the exception of the five age groups from 3 months through 2 years; for each of these age groups, between 28 and 48 sera were tested. For Fig. 1 C, The similar patterns observed with the three serological tests are apparent (Fig. 1 ). Antibody present in the 0-to 3-month-old age group presumably was of maternal origin. The percentage of sera with antibody diminished for the next several months, and was then followed by a sharp rise in the frequency of antibody. CF antibody to the human reovirus-like agent of presumed maternal origin diminished at a precipitous rate, so that only 3 of 28 sera in the 3-to 6-month-old age group were positive. A fall in FA staining and CF antibodies to NCDV was also apparent; however, the decline was not as precipitous as with antibody to the human agent, and thus the lowest levels of antibody to NCDV were noted in the 6-to 9-month-old age group. It is clear from Fig. 1 Although there was a highly significant association between the results of CF tests with the human and calf antigens, this concordance was not observed with one-third of the sera tested. Analysis of the sera of 110 Washington, D.C. children produced similar findings (11) . It population. However, even though a selected population was studied, the data do help to provide a valuable overview of the age prevalence of antibody in the Boston metropolitan area, and of the inter-relationships between three serological assays. The findings are in substantial agreement with the preliminary findings noted in the Washington, D.C. population (11) . Most of the sera examined in this Boston Children's Hospital series were obtained within 3 days of hospital admission, and all but a few patients were hospitalized for nonfatal disease. There were no in-hospital outbreaks of diarrhea during the 3 months that sera were collected, and children with inflammatory gastrointestinal disease or hematological disease requiring transfusion were excluded from the study. Further studies will be necessary to compare serological results obtained in patients from high and low socioeconomic backgrounds.
